360 related articles for article (PubMed ID: 33690604)
1. Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease.
Rana T; Korolkova OY; Rachakonda G; Williams AD; Hawkins AT; James SD; Sakwe AM; Hui N; Wang L; Yu C; Goodwin JS; Izban MG; Offodile RS; Washington MK; Ballard BR; Smoot DT; Shi XZ; Forbes DS; Shanker A; M'Koma AE
PLoS One; 2021; 16(3):e0246393. PubMed ID: 33690604
[TBL] [Abstract][Full Text] [Related]
2. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.
Williams AD; Korolkova OY; Sakwe AM; Geiger TM; James SD; Muldoon RL; Herline AJ; Goodwin JS; Izban MG; Washington MK; Smoot DT; Ballard BR; Gazouli M; M'Koma AE
PLoS One; 2017; 12(8):e0179710. PubMed ID: 28817680
[TBL] [Abstract][Full Text] [Related]
3. Implications of the colonic deposition of free hemoglobin-α chain: a previously unknown tissue by-product in inflammatory bowel disease.
Myers JN; Schäffer MW; Korolkova OY; Williams AD; Gangula PR; M'Koma AE
Inflamm Bowel Dis; 2014 Sep; 20(9):1530-47. PubMed ID: 25078150
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitous Colonic Ileal Metaplasia Consistent with the Diagnosis of Crohn's Colitis among Indeterminate Colitis Cohorts.
Breaux WA; Bragg MA; M'Koma AE
Med Res Arch; 2023 Aug; 11(8):. PubMed ID: 37854669
[TBL] [Abstract][Full Text] [Related]
5. The MYTHS of
James SD; Hawkins AT; Um JW; Ballard BR; Smoot DT; M'Koma AE
Jpn J Gastroenterol Hepatol; 2020; 3(2):. PubMed ID: 37584007
[TBL] [Abstract][Full Text] [Related]
6. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
[TBL] [Abstract][Full Text] [Related]
7. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
[TBL] [Abstract][Full Text] [Related]
8. Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis.
Seeley EH; Washington MK; Caprioli RM; M'Koma AE
Proteomics Clin Appl; 2013 Aug; 7(7-8):541-9. PubMed ID: 23382084
[TBL] [Abstract][Full Text] [Related]
9. Intestinal alpha-defensin expression in pediatric inflammatory bowel disease.
Zilbauer M; Jenke A; Wenzel G; Goedde D; Postberg J; Phillips AD; Lucas M; Noble-Jamieson G; Torrente F; Salvestrini C; Heuschkel R; Wirth S
Inflamm Bowel Dis; 2011 Oct; 17(10):2076-86. PubMed ID: 21910169
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis.
Fahlgren A; Hammarström S; Danielsson A; Hammarström ML
Clin Exp Immunol; 2003 Jan; 131(1):90-101. PubMed ID: 12519391
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population.
Ferguson LR; Browning BL; Huebner C; Petermann I; Shelling AN; Demmers P; McCulloch A; Gearry RB; Barclay ML; Philpott M
Dig Liver Dis; 2008 Sep; 40(9):723-30. PubMed ID: 18394979
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor expression in crypt epithelial cells, putative stem cells and intestinal myofibroblasts isolated from controls and patients with inflammatory bowel disease.
Brown M; Hughes KR; Moossavi S; Robins A; Mahida YR
Clin Exp Immunol; 2014 Oct; 178(1):28-39. PubMed ID: 24828022
[TBL] [Abstract][Full Text] [Related]
13. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.
Wehkamp J; Fellermann K; Herrlinger KR; Baxmann S; Schmidt K; Schwind B; Duchrow M; Wohlschläger C; Feller AC; Stange EF
Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):745-52. PubMed ID: 12169983
[TBL] [Abstract][Full Text] [Related]
14. Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins.
Wehkamp J; Schwind B; Herrlinger KR; Baxmann S; Schmidt K; Duchrow M; Wohlschläger C; Feller AC; Stange EF; Fellermann K
Dig Dis Sci; 2002 Jun; 47(6):1349-55. PubMed ID: 12064812
[TBL] [Abstract][Full Text] [Related]
15. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease.
Østvik AE; Svendsen TD; Granlund AVB; Doseth B; Skovdahl HK; Bakke I; Thorsvik S; Afroz W; Walaas GA; Mollnes TE; Gustafsson BI; Sandvik AK; Bruland T
J Crohns Colitis; 2020 Jul; 14(7):920-934. PubMed ID: 32020185
[TBL] [Abstract][Full Text] [Related]
16. Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease.
Koslowski MJ; Teltschik Z; Beisner J; Schaeffeler E; Wang G; Kübler I; Gersemann M; Cooney R; Jewell D; Reinisch W; Vermeire S; Rutgeerts P; Schwab M; Stange EF; Wehkamp J
PLoS Genet; 2012; 8(2):e1002523. PubMed ID: 22393312
[TBL] [Abstract][Full Text] [Related]
17. Defensins and inflammation: the role of defensins in inflammatory bowel disease.
Ramasundara M; Leach ST; Lemberg DA; Day AS
J Gastroenterol Hepatol; 2009 Feb; 24(2):202-8. PubMed ID: 19215333
[TBL] [Abstract][Full Text] [Related]
18.
Loganes C; Valencic E; Pin A; Marini E; Martelossi S; Naviglio S; De Leo L; Not T; Monasta L; Tommasini A; Marcuzzi A
World J Gastroenterol; 2016 Nov; 22(44):9734-9743. PubMed ID: 27956797
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease.
Gibson P; Rosella O
Gut; 1995 Oct; 37(4):536-43. PubMed ID: 7489942
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies.
Manousou P; Kolios G; Valatas V; Drygiannakis I; Bourikas L; Pyrovolaki K; Koutroubakis I; Papadaki HA; Kouroumalis E
Clin Exp Immunol; 2010 Nov; 162(2):337-47. PubMed ID: 21077277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
